Hanover - Hanover Delayed Price. Currency in EUR
-0.25 (-0.48%)
At close: 8:10AM CET
Stock chart is not supported by your current browser
Previous Close52.10
Bid0.00 x 0
Ask0.00 x 0
Day's Range51.85 - 51.85
52 Week Range34.14 - 54.45
Avg. Volume4
Market CapN/A
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Reuters7 months ago

    Valeant to sell iNova unit for $930 mln to repay debt

    Valeant Pharmaceuticals International Inc said it would sell its iNova Pharmaceuticals business for $930 million, as Chief Executive Officer Joseph Papa steps up efforts to slash the embattled Canadian drugmaker's huge debt pile. The company's U.S.-listed shares were up about 3.5 percent at $12.60 in premarket trading on Thursday.

  • Reuters7 months ago

    Valeant in talks to sell eye-surgery assets to Carl Zeiss - Bbg

    Canadian drugmaker Valeant Pharmaceuticals International Inc is in talks to sell its Bausch & Lomb unit's surgical products business to Germany's Carl Zeiss Meditec AG, Bloomberg reported. Valeant's eye-surgery assets may be valued at about $2 billion in a sale, Bloomberg reported, citing people familiar with the matter. "We don't comment on speculation or rumors," Valeant spokeswoman Lainie Keller said in an email.

  • We're sorry this is all we were able to find about this topic.